Document Detail


Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies.
MedLine Citation:
PMID:  15193867     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Placental tissue protein 13 (PP-13), one of the 56 known placental proteins identified till today, was purified from placentas obtained from women at delivery, and used to evoke antibodies against it. The purified PP-13 was lysed to peptides, which were sequenced, leading to the full-length cDNA sequencing and its expression in Escherichia coli. Sequence analysis in databases showed homology to the galectin family. Of the various antibody preparations developed, a pair of monoclonal antibodies (MAbs) coupled to the recombinant PP-13 (PP-13-R) was used for the immunodetection of PP-13 in pregnant women's serum with the solid-phase ELISA format. With a dynamic range of 25-500 pg/mL with no background in non-pregnant women's serum and men's serum, the ELISA test was suitable for the detection of PP-13 in the 1st, 2nd, and 3rd trimesters. PP-13 levels slowly increase during pregnancy. In the 1st trimester, lower than normal PP-13 levels were found in fetal growth restriction (IUGR), preeclampsia (PE), and particularly in early PE (<34 weeks of gestation). In the 2nd and 3rd trimesters, higher than normal concentrations were found in PE, IUGR and in preterm delivery (PTD). Application of PP-13 to cultured trophoblasts elicited depolarization carried by calcium ions, followed by liberation of linoleic and arachidonic acids from the trophoblast membrane, and a subsequent elevation of prostacyclin and thromboxane. These effects were negligible when PP-13 derived from the placentas of patients with IUGR, PE or PTD was used. The results are discussed in view of the potential utilization of PP-13 for early serum screening to assess the risk to develop placental insufficiency, coupled to a differential analysis of the various pathologies by analyzing cultured trophoblasts.
Authors:
O Burger; E Pick; J Zwickel; M Klayman; H Meiri; R Slotky; S Mandel; L Rabinovitch; Y Paltieli; A Admon; R Gonen
Related Documents :
7409607 - First-trimester serum prolactin levels in normal and complicated pregnancies.
445857 - Serum beta-hexosaminidases in pregnancy.
16649967 - Peripartum maternal and foetal ghrelin, growth hormones, igfs and insulin interrelations.
8608817 - Morphological and biochemical effects of excessive amounts of biotin on embryonic devel...
18055727 - Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body m...
7657747 - Cumulative conception rate following intrauterine artificial insemination with husband'...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Placenta     Volume:  25     ISSN:  0143-4004     ISO Abbreviation:  Placenta     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2004-06-14     Completed Date:  2004-12-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  England    
Other Details:
Languages:  eng     Pagination:  608-22     Citation Subset:  IM    
Affiliation:
Diagnostic Technology, 49 Ha'Histadrut St., PO Box 25266, Haifa 31250, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Amniotic Fluid / chemistry
Animals
Antibodies, Monoclonal
Base Sequence
Body Fluids / chemistry*
Cells, Cultured
DNA, Complementary / analysis,  chemistry
Enzyme-Linked Immunosorbent Assay
Female
Fetal Growth Retardation / metabolism
Galectins
Gestational Age
Humans
Mice
Mice, Inbred BALB C
Molecular Sequence Data
Obstetric Labor, Premature
Pre-Eclampsia / metabolism
Pregnancy
Pregnancy Complications / metabolism*
Pregnancy Proteins / analysis*,  genetics,  pharmacology*
Radioimmunoassay
Recombinant Proteins
Sensitivity and Specificity
Sequence Homology
Trophoblasts / drug effects*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/DNA, Complementary; 0/Galectins; 0/LGALS13 protein, human; 0/Pregnancy Proteins; 0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gap junctions are required for trophoblast proliferation in early human placental development.
Next Document:  Eph and ephrin expression in normal placental development and preeclampsia.